INSIGHTS ON LIQUID DOSE MANUFACTURING

• BioTitan Retention Device Overview

  Learn about a retention device that provides robust fortification for single-use assemblies. Its 360-degree seal strengthens connections, reduces leak risks, and ensures process integrity for fluid transfer.

• Isolated GENiSYS C Fill-Finish System: Available For Quick Delivery

  Accelerate your parenteral drug production with a fully integrated, isolator-based fill-finish system. Compact design, rapid delivery, and maximum yield for agile drug development.

• Lifecycle Planning For Containment And Delivery Of Biologics Drug Products

  Read more about trends in the biologics market that could impact the lifecycle strategies for your drug product and steps you can take around drug packaging early in development.

• Importance Of Assessing Mannitol Crystallinity In Lyophilized Drug Products

  Drug product stability may be seriously compromised if mannitol completes crystallization during storage rather than during the freezing or annealing step in the lyophilization process.

• Empowering Innovation: Harnessing CDMO Potential For Sterile Injectables

  10/20/2025

  Specialized CDMOs are essential for meeting the growing demand and complex quality requirements for sterile injectables. Outsourcing provides crucial benefits like cost savings, flexibility, and a strategic focus on core competencies.

• CDMO Partnerships: Why Speed And Flexibility Matter Now More Than Ever

  12/29/2025

  As demand for GLP-1s and biologics accelerates and timelines compress, it's become more crucial that pharmaceutical companies stay competitive and bring therapies to market faster by partnering with a CDMO.

• Service Solutions Designed To Help You Gain Speed To Clinic And Market

  4/28/2025

  Discover how speed, cost, and regulatory acceptance impact drug manufacturing, as well as learn about aseptic filling challenges and how innovative services can enhance your efficiency and compliance.

• Sterility Testing Of Products With Antimicrobial Properties

  6/4/2024

  Drugs formulated with antibiotics, preservatives, or other chemicals may inhibit microbial viability and growth. Learn more about three golden rules to be effective against antimicrobial effects.

• Navigating The New USP Chapter <382> For Elastomeric Closures

  6/24/2025

  Dive into the scope of <382> for pharmaceutical closures and the regulatory landscape, which includes new required tests, instrumentation for compliance, and recommendations on implementation.